Authors: Tibor Deutsch, D. G. Cramp, Ewart R. Carson
Hardbound. In virtually all countries concerns are being expressed over the
rising cost of the medicines component of health budgets, the safety of medicines, their inappropriate use and more recently ethical issues arising from the use of therapies resulting from
developments in molecular biology and genetics. Purchasers of pharmaceuticals demand value for money as well as efficacy and safety in order to use their resources more efficiently. Furthermore, they expect companies in the pharmaceutical industry to provide economic arguments for the use of each product. Pharmaceutical companies have responded by recognising that relative
clinical benefits, quality of life, the effect on disease…
